About
Paul Russell is a UK-based biopharma development executive and currently Chief Development Officer at Juvenescence, a longevity-focused clinical-stage biotech. Juvenescence says he joined in late 2025 after serving as Head of Development at Enterprise Therapeutics, where he led development strategy from candidate selection through Phase 2. Earlier roles included Director of Early Clinical Development and Project Leader at RespiVert/Janssen and senior respiratory clinical pharmacology leadership roles at GSK, plus experience at Servier and AstraZeneca.
Areas of interest
longevitybiotechdrug developmentclinical developmentrespiratory diseasefibrotic diseaseaging therapeuticspharmacology